OtoNexus is developing the world’s first medical device to provide objective diagnostic data to instantly and accurately diagnose middle ear infections (Otitis Media) in children and adults. A simple and elegant solution, the device applies a well-known medical technology, ultrasound, in a completely novel way to achieve a key advance in differentiating when and when not to prescribe antibiotics. One-use-per-patient tips create a recurring revenue stream. The device will provide data in seconds and will be easy to use by physicians or non-physician personnel (NPs, PAs). Definitive, objective data identifying both the presence and the type of fluid behind the eardrum will lead to better outcomes and significantly reduced healthcare costs.
Location: United States, Washington, Bellevue
Employees: 11-50
Founded date: 2010
Investors 13
Show more
Mentions in press and media 1
| Date | Title | Description |
| 23.02.2016 | Northwest angel investment collective Keiretsu doles out $43.5M in 2015 | Photo via Shutterstock. The Keiretsu Forum Northwest announced today in a news release that its regional collective of angel investors poured $43.5 million into 57 companies this past year, making 2015 the biggest year for investments by th... |